127 related articles for article (PubMed ID: 18541788)
21. [Therapy of Parkinson's disease 2008].
Deuschl G
MMW Fortschr Med; 2008 May; 150 Suppl 2():60-3. PubMed ID: 18678055
[No Abstract] [Full Text] [Related]
22. The nigrostriatal pathway in Creutzfeldt-Jakob disease.
Vital A; Fernagut PO; Canron MH; Joux J; Bezard E; Martin-Negrier ML; Vital C; Tison F
J Neuropathol Exp Neurol; 2009 Jul; 68(7):809-15. PubMed ID: 19535991
[TBL] [Abstract][Full Text] [Related]
23. Impact of grafted serotonin and dopamine neurons on development of L-DOPA-induced dyskinesias in parkinsonian rats is determined by the extent of dopamine neuron degeneration.
Carlsson T; Carta M; Muñoz A; Mattsson B; Winkler C; Kirik D; Björklund A
Brain; 2009 Feb; 132(Pt 2):319-35. PubMed ID: 19039008
[TBL] [Abstract][Full Text] [Related]
24. [An autopsy case of striato-nigral and olivo-ponto-cerebellar degeneration (author's transl)].
Riku S; Hashizume Y; Yanagi T; Sobue I
Rinsho Shinkeigaku; 1980 Jul; 20(7):534-8. PubMed ID: 7460423
[No Abstract] [Full Text] [Related]
25. [Striano-nigral degeneration].
Mizuno Y
Nihon Rinsho; 1978 May; Suppl():1720-1. PubMed ID: 691494
[No Abstract] [Full Text] [Related]
26. Re: Gout and risk of Parkinson disease: a prospective study.
Schlesinger I; Schlesinger N
Neurology; 2008 Jul; 71(1):70; author reply 70. PubMed ID: 18598007
[No Abstract] [Full Text] [Related]
27. Striatonigral degeneration response to levodopa therapy.
Rajput AH; Kazi KH; Rozdilsky B
J Neurol Sci; 1972 Jul; 16(3):331-41. PubMed ID: 5038888
[No Abstract] [Full Text] [Related]
28. Serum uric acid and albumin are affected by different variables in Parkinson's disease.
Hemmati-Dinarvand M; Niknam M; Zununi Vahed S; Samadi N
Neurol Sci; 2019 Jan; 40(1):187-188. PubMed ID: 30140989
[No Abstract] [Full Text] [Related]
29. [Huntington disease].
Kanazawa I
Ryoikibetsu Shokogun Shirizu; 1999; (27 Pt 2):86-8. PubMed ID: 10434598
[No Abstract] [Full Text] [Related]
30. A comparative study of Parkinsonism and other extrapyramidal system disorders.
Neumann MA
J Neuropathol Exp Neurol; 1968 Jan; 27(1):152-3. PubMed ID: 5656567
[No Abstract] [Full Text] [Related]
31. Ultrastructural observations in Parkinsonism.
Roy S; Wolman L
J Pathol; 1969 Sep; 99(1):39-44. PubMed ID: 5359222
[No Abstract] [Full Text] [Related]
32. Anatomical and functional reconstruction of the nigrostriatal pathway by intranigral transplants.
Gaillard A; Decressac M; Frappé I; Fernagut PO; Prestoz L; Besnard S; Jaber M
Neurobiol Dis; 2009 Sep; 35(3):477-88. PubMed ID: 19616502
[TBL] [Abstract][Full Text] [Related]
33. Indirect-pathway neurons lose their spines in Parkinson disease.
Gerfen CR
Nat Neurosci; 2006 Feb; 9(2):157-8. PubMed ID: 16439979
[No Abstract] [Full Text] [Related]
34. Targeted overexpression of the parkin substrate Pael-R in the nigrostriatal system of adult rats to model Parkinson's disease.
Dusonchet J; Bensadoun JC; Schneider BL; Aebischer P
Neurobiol Dis; 2009 Jul; 35(1):32-41. PubMed ID: 19348945
[TBL] [Abstract][Full Text] [Related]
35. The search for biomarkers in Parkinson's disease: a critical review.
Antoniades CA; Barker RA
Expert Rev Neurother; 2008 Dec; 8(12):1841-52. PubMed ID: 19086880
[TBL] [Abstract][Full Text] [Related]
36. Natural oxidant balance in Parkinson disease.
Perry G; Moreira PI; Siedlak SL; Nunomura A; Zhu X; Smith MA
Arch Neurol; 2009 Dec; 66(12):1445. PubMed ID: 20008647
[No Abstract] [Full Text] [Related]
37. Urate as a marker of development and progression in Parkinson's disease.
Constantinescu R; Zetterberg H
Drugs Today (Barc); 2011 May; 47(5):369-80. PubMed ID: 22013567
[TBL] [Abstract][Full Text] [Related]
38. Uric acid in CHF: marker or player in a metabolic disease?
Doehner W; von Haehling S; Anker SD
Int J Cardiol; 2007 Feb; 115(2):156-8. PubMed ID: 16844250
[No Abstract] [Full Text] [Related]
39. The effect of calcium supplementation on serum urate: analysis of a randomized controlled trial.
Dalbeth N; Horne A; Gamble GD; Ames R; Mason B; McQueen FM; Bolland MJ; Grey A; Reid IR
Rheumatology (Oxford); 2009 Feb; 48(2):195-7. PubMed ID: 19036779
[No Abstract] [Full Text] [Related]
40. Nigral pathology in older persons without Parkinson disease.
Jellinger KA; Attems J
Ann Neurol; 2012 Aug; 72(2):297; author reply 298. PubMed ID: 22926864
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
